Recursion Pharmaceuticals Inc
NASDAQ:RXRX

Watchlist Manager
Recursion Pharmaceuticals Inc Logo
Recursion Pharmaceuticals Inc
NASDAQ:RXRX
Watchlist
Price: 5.7 USD -0.87% Market Closed
Market Cap: 1.6B USD
Have any thoughts about
Recursion Pharmaceuticals Inc?
Write Note

Income Statement

Earnings Waterfall
Recursion Pharmaceuticals Inc

Revenue
65.2m USD
Cost of Revenue
-42.3m USD
Gross Profit
22.9m USD
Operating Expenses
-417m USD
Operating Income
-394.2m USD
Other Expenses
16.4m USD
Net Income
-377.8m USD

Income Statement
Recursion Pharmaceuticals Inc

Rotate your device to view
Income Statement
Currency: USD
Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024
Revenue
Revenue
8
N/A
10
+33%
13
+27%
18
+40%
29
+59%
40
+39%
47
+17%
50
+7%
47
-5%
45
-6%
46
+4%
50
+7%
65
+31%
Gross Profit
Cost of Revenue
0
0
(8)
(22)
(37)
(48)
(53)
(48)
(44)
(43)
(41)
(41)
(42)
Gross Profit
0
N/A
0
N/A
(2)
N/A
(9)
-265%
(11)
-25%
(8)
+25%
(6)
+26%
2
N/A
4
+99%
2
-48%
5
+148%
9
+72%
23
+168%
Operating Income
Operating Expenses
(125)
(193)
(214)
(227)
(238)
(237)
(249)
(276)
(315)
(351)
(380)
(404)
(417)
Selling, General & Administrative
(38)
(67)
(72)
(77)
(80)
(96)
(83)
(93)
(103)
(134)
(125)
(128)
(137)
Research & Development
(87)
(126)
(141)
(150)
(157)
(141)
(166)
(181)
(207)
(208)
(244)
(260)
(264)
Depreciation & Amortization
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(2)
(5)
(9)
(12)
(14)
(15)
Operating Income
(118)
N/A
(183)
-55%
(209)
-14%
(231)
-10%
(247)
-7%
(246)
+0%
(256)
-4%
(274)
-7%
(311)
-13%
(349)
-12%
(375)
-8%
(395)
-5%
(394)
+0%
Pre-Tax Income
Interest Income Expense
(3)
(3)
(3)
1
3
6
11
15
18
19
18
16
15
Non-Reccuring Items
(1)
(1)
0
(4)
(3)
0
(4)
(1)
(1)
(1)
(1)
0
0
Total Other Income
(0)
0
(0)
(0)
0
0
0
0
1
(1)
(1)
(1)
(3)
Pre-Tax Income
(122)
N/A
(186)
-53%
(212)
-14%
(234)
-10%
(247)
-6%
(239)
+3%
(249)
-4%
(260)
-4%
(293)
-13%
(332)
-14%
(359)
-8%
(380)
-6%
(383)
-1%
Net Income
Tax Provision
0
0
0
0
0
0
0
0
0
4
5
5
5
Income from Continuing Operations
(122)
(186)
(212)
(234)
(247)
(239)
(249)
(260)
(293)
(328)
(354)
(375)
(378)
Net Income (Common)
(122)
N/A
(186)
-53%
(212)
-14%
(234)
-10%
(247)
-6%
(239)
+3%
(249)
-4%
(260)
-4%
(293)
-13%
(328)
-12%
(354)
-8%
(375)
-6%
(378)
-1%
EPS (Diluted)
-0.72
N/A
-1.49
-107%
-1.24
+17%
-1.37
-10%
-1.44
-5%
-1.36
+6%
-1.29
+5%
-1.32
-2%
-1.37
-4%
-1.58
-15%
-1.5
+5%
-1.54
-3%
-1.33
+14%

See Also

Discover More